ReP USP - Resultado da busca

Artigo de periodico
Reduced Annexin A3 in schizophrenia (2020)
Joaquim, Helena P. G; Costa, Alana Caroline; Serpa, Mauricio Henriques; Talib, Leda L; Gattaz, Wagner Farid
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: ESQUIZOFRENIA, TRANSTORNO BIPOLAR, BIOMARCADORES, PROTEÍNAS DE LIGAÇÃO DO CÁLCIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G; COSTA, Alana Caroline; SERPA, Mauricio Henriques; TALIB, Leda L; GATTAZ, Wagner Farid. Reduced Annexin A3 in schizophrenia. European archives of psychiatry and clinical neuroscience, Heidelberg, v. 270, n. 4, p. 489-494, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/36060 > DOI: 10.1007/s00406-019-01048-3.
APA
Joaquim, H. P. G., Costa, A. C., Serpa, M. H., Talib, L. L., & Gattaz, W. F. (2020). Reduced Annexin A3 in schizophrenia. European archives of psychiatry and clinical neuroscience, 270( 4), 489-494. doi:10.1007/s00406-019-01048-3
NLM
Joaquim HPG, Costa AC, Serpa MH, Talib LL, Gattaz WF. Reduced Annexin A3 in schizophrenia [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 489-494.Available from: https://observatorio.fm.usp.br/handle/OPI/36060
Vancouver
Joaquim HPG, Costa AC, Serpa MH, Talib LL, Gattaz WF. Reduced Annexin A3 in schizophrenia [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 489-494.Available from: https://observatorio.fm.usp.br/handle/OPI/36060
Artigo de periodico
Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study (2020)
Kambeitz, Joseph; Goerigk, Stephan; Gattaz, Wagner Farid ; Falkai, Peter; Benseñor, Isabela Judith Martins ; Lotufo, Paulo Andrade ; Buehner, Markus; Koutsouleris, Nikolaos; Padberg, Frank; Brunoni, Andre Russowsky
Source: Journal of affective disorders. Unidade: FM
Subjects: DEPRESSÃO, PSICOTERAPIA, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAMBEITZ, Joseph; GOERIGK, Stephan; GATTAZ, Wagner Farid; et al. Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study. Journal of affective disorders, Amsterdam, v. 265, p. 460-467, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/36066 > DOI: 10.1016/j.jad.2020.01.118.
APA
Kambeitz, J., Goerigk, S., Gattaz, W. F., Falkai, P., Benseñor, I. J. M., Lotufo, P. A., et al. (2020). Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study. Journal of affective disorders, 265, 460-467. doi:10.1016/j.jad.2020.01.118
NLM
Kambeitz J, Goerigk S, Gattaz WF, Falkai P, Benseñor IJM, Lotufo PA, Buehner M, Koutsouleris N, Padberg F, Brunoni AR. Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study [Internet]. Journal of affective disorders. 2020 ; 265 460-467.Available from: https://observatorio.fm.usp.br/handle/OPI/36066
Vancouver
Kambeitz J, Goerigk S, Gattaz WF, Falkai P, Benseñor IJM, Lotufo PA, Buehner M, Koutsouleris N, Padberg F, Brunoni AR. Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study [Internet]. Journal of affective disorders. 2020 ; 265 460-467.Available from: https://observatorio.fm.usp.br/handle/OPI/36066
Artigo de periodico
Differences in the immune-inflammatory profiles of unipolar and bipolar depression (2020)
Brunoni, André Russowsky ; Supasitthumrong, Thitiporn; Teixeira, Antonio Lucio; Vieira, Erica L. M.; Gattaz, Wagner Farid ; Benseñor, Isabela Judith Martins ; Lotufo, Paulo Andrade ; Lafer, Beny ; Berk, Michael; Carvalho, Andre F; Maes, Michael
Source: Journal of affective disorders. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, DEPRESSÃO, INFLAMAÇÃO, CITOCINAS, BIOMARCADORES, TESTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNONI, André Russowsky; SUPASITTHUMRONG, Thitiporn; TEIXEIRA, Antonio Lucio; et al. Differences in the immune-inflammatory profiles of unipolar and bipolar depression. Journal of affective disorders, Amsterdam, v. 262, p. 8-15, 2020. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34263 > DOI: 10.1016/j.jad.2019.10.037.
APA
Brunoni, A. R., Supasitthumrong, T., Teixeira, A. L., Vieira, E. L. M., Gattaz, W. F., Benseñor, I. J. M., et al. (2020). Differences in the immune-inflammatory profiles of unipolar and bipolar depression. Journal of affective disorders, 262, 8-15. doi:10.1016/j.jad.2019.10.037
NLM
Brunoni AR, Supasitthumrong T, Teixeira AL, Vieira ELM, Gattaz WF, Benseñor IJM, Lotufo PA, Lafer B, Berk M, Carvalho AF, Maes M. Differences in the immune-inflammatory profiles of unipolar and bipolar depression [Internet]. Journal of affective disorders. 2020 ; 262 8-15.Available from: http://observatorio.fm.usp.br/handle/OPI/34263
Vancouver
Brunoni AR, Supasitthumrong T, Teixeira AL, Vieira ELM, Gattaz WF, Benseñor IJM, Lotufo PA, Lafer B, Berk M, Carvalho AF, Maes M. Differences in the immune-inflammatory profiles of unipolar and bipolar depression [Internet]. Journal of affective disorders. 2020 ; 262 8-15.Available from: http://observatorio.fm.usp.br/handle/OPI/34263
Artigo de periodico
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study (2020)
Costa, Alana C.; Joaquim, Helena P. G.; Forlenza, Orestes Vicente ; Gattaz, Wagner Farid ; Talib, Leda L
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: METABOLÔMICA, TRANSTORNOS COGNITIVOS, BIOMARCADORES, DOENÇA DE ALZHEIMER, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C.; JOAQUIM, Helena P. G.; FORLENZA, Orestes Vicente; GATTAZ, Wagner Farid; TALIB, Leda L. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, Heidelberg, v. 270, n. 4, p. 483-488, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/36059 > DOI: 10.1007/s00406-019-01034-9.
APA
Costa, A. C., Joaquim, H. P. G., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2020). Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, 270( 4), 483-488. doi:10.1007/s00406-019-01034-9
NLM
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.Available from: https://observatorio.fm.usp.br/handle/OPI/36059
Vancouver
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.Available from: https://observatorio.fm.usp.br/handle/OPI/36059
Artigo de periodico
Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial (2020)
Brunoni, Andre Russowsky ; Carracedo, Angel; Amigo, Olalla M; Pellicer, Ana L; Talib, Leda; Carvalho, Andre F; Lotufo, Paulo Andrade ; Benseñor, Isabela Judith Martins ; Gattaz, Wagner Farid ; Cappi, Carolina
Source: Brazilian journal of psychiatry. Unidade: FM
Subjects: ANTIDEPRESSIVOS, DEPRESSÃO, MÉTODO DUPLO-CEGO, POLIMORFISMO, OXIGENASE, TERAPIA COMBINADA, TRANSFERASES, AMINAS (COMPOSTOS ORGÂNICOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNONI, Andre Russowsky; CARRACEDO, Angel; AMIGO, Olalla M; et al. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian journal of psychiatry, Sao Paulo, v. 42, n. 2, p. 128-135, 2020. Disponível em: < https://observatorio.fm.usp.br/handle/OPI/35831 > DOI: 10.1590/1516-4446-2019-0620.
APA
Brunoni, A. R., Carracedo, A., Amigo, O. M., Pellicer, A. L., Talib, L., Carvalho, A. F., et al. (2020). Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian journal of psychiatry, 42( 2), 128-135. doi:10.1590/1516-4446-2019-0620
NLM
Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, Lotufo PA, Benseñor IJM, Gattaz WF, Cappi C. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 2): 128-135.Available from: https://observatorio.fm.usp.br/handle/OPI/35831
Vancouver
Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, Lotufo PA, Benseñor IJM, Gattaz WF, Cappi C. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 2): 128-135.Available from: https://observatorio.fm.usp.br/handle/OPI/35831
Artigo de periodico
Disclosing the diagnosis of schizophrenia: a pilot study of the 'Coming Out Proud' intervention (2019)
Setti, Viviane Piagentini Candal; Loch, Alexandre Andrade; Modelli, Arlete; Rocca, Cristiana Castanho de Almeida; Hungerbuehler, Ines; Bilt, Martinus Theodorus van de; Gattaz, Wagner Farid; Roessler, Wulf
Source: International journal of social psychiatry. Unidade: FM
Subjects: ESTIGMA, SAÚDE MENTAL, ESQUIZOFRENIA, QUALIDADE DE VIDA, TRANSTORNOS MENTAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SETTI, Viviane Piagentini Candal; LOCH, Alexandre Andrade; MODELLI, Arlete; et al. Disclosing the diagnosis of schizophrenia: a pilot study of the 'Coming Out Proud' intervention. International journal of social psychiatry, London, v. 65, n. 3, p. 244-251, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/32522 > DOI: 10.1177/0020764019840057.
APA
Setti, V. P. C., Loch, A. A., Modelli, A., Rocca, C. C. de A., Hungerbuehler, I., Bilt, M. T. van de, et al. (2019). Disclosing the diagnosis of schizophrenia: a pilot study of the 'Coming Out Proud' intervention. International journal of social psychiatry, 65( 3), 244-251. doi:10.1177/0020764019840057
NLM
Setti VPC, Loch AA, Modelli A, Rocca CC de A, Hungerbuehler I, Bilt MT van de, Gattaz WF, Roessler W. Disclosing the diagnosis of schizophrenia: a pilot study of the 'Coming Out Proud' intervention [Internet]. International journal of social psychiatry. 2019 ; 65( 3): 244-251.Available from: http://observatorio.fm.usp.br/handle/OPI/32522
Vancouver
Setti VPC, Loch AA, Modelli A, Rocca CC de A, Hungerbuehler I, Bilt MT van de, Gattaz WF, Roessler W. Disclosing the diagnosis of schizophrenia: a pilot study of the 'Coming Out Proud' intervention [Internet]. International journal of social psychiatry. 2019 ; 65( 3): 244-251.Available from: http://observatorio.fm.usp.br/handle/OPI/32522
Artigo de periodico
Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients (2019)
Bram, Jessyka Maria de Franca; Talib, Leda Leme; Joaquim, Helena Passarelli Giroud; Sarno, Tamires Alves; Gattaz, Wagner Farid ; Forlenza, Orestes Vicente
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, BIOMARCADORES, LEUCÓCITOS, PROTEÍNAS DA MEMBRANA, PLAQUETAS SANGUÍNEAS, ENZIMAS PROTEOLÍTICAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAM, Jessyka Maria de Franca; TALIB, Leda Leme; JOAQUIM, Helena Passarelli Giroud; et al. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, Heidelberg, v. 269, n. 8, p. 963-972, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34535 > DOI: 10.1007/s00406-018-0905-3.
APA
Bram, J. M. de F., Talib, L. L., Joaquim, H. P. G., Sarno, T. A., Gattaz, W. F., & Forlenza, O. V. (2019). Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 269( 8), 963-972. doi:10.1007/s00406-018-0905-3
NLM
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.Available from: http://observatorio.fm.usp.br/handle/OPI/34535
Vancouver
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.Available from: http://observatorio.fm.usp.br/handle/OPI/34535
Artigo de periodico
Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy (2019)
Vincentiis, Silvia; Alcantara, Juliana; Rzezak, Patricia; Kerr, Daniel; Santos, Bernardo dos; Alessi, Ruda; Linden, Helio van der; Arruda, Francisco; Chaim-avancini, Tiffany; Serpa, Mauricio; Busatto Filho, Geraldo; Gattaz, Wagner Farid
Source: Epilepsy research. Unidade: FM
Subjects: POLIMORFISMO, EPILEPSIA DO LOBO TEMPORAL, SEROTONINA, ENZIMAS OXIRREDUTORAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINCENTIIS, Silvia; ALCANTARA, Juliana; RZEZAK, Patricia; et al. Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy. Epilepsy research, Amsterdam, v. 149, p. 26-29, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/30897 > DOI: 10.1016/j.eplepsyres.2018.11.003.
APA
Vincentiis, S., Alcantara, J., Rzezak, P., Kerr, D., Santos, B. dos, Alessi, R., et al. (2019). Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy. Epilepsy research, 149, 26-29. doi:10.1016/j.eplepsyres.2018.11.003
NLM
Vincentiis S, Alcantara J, Rzezak P, Kerr D, Santos B dos, Alessi R, Linden H van der, Arruda F, Chaim-avancini T, Serpa M, Busatto Filho G, Gattaz WF. Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy [Internet]. Epilepsy research. 2019 ; 149 26-29.Available from: http://observatorio.fm.usp.br/handle/OPI/30897
Vancouver
Vincentiis S, Alcantara J, Rzezak P, Kerr D, Santos B dos, Alessi R, Linden H van der, Arruda F, Chaim-avancini T, Serpa M, Busatto Filho G, Gattaz WF. Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy [Internet]. Epilepsy research. 2019 ; 149 26-29.Available from: http://observatorio.fm.usp.br/handle/OPI/30897
Artigo de periodico
Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: evidence from the ELECT-TDCS trial (2019)
Bulubas, Lucia; Padberg, Frank; V, Priscila Bueno; Duran, Fabio; Busatto Filho, Geraldo ; Amaro Junior, Edson ; Benseñor, Isabela Judith Martins ; Lotufo, Paulo Andrade ; Goerigk, Stephan; Gattaz, Wagner Farid
Source: Brain stimulation. Unidade: FM
Subjects: SEROTONINA, TERAPIA POR ESTIMULAÇÃO ELÉTRICA, DEPRESSÃO, ANTIDEPRESSIVOS, CÓRTEX PRÉ-FRONTAL, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BULUBAS, Lucia; PADBERG, Frank; V, Priscila Bueno; et al. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: evidence from the ELECT-TDCS trial. Brain stimulation, New York, v. 12, n. 5, p. 1197-1204, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/33551 > DOI: 10.1016/j.brs.2019.05.006.
APA
Bulubas, L., Padberg, F., V, P. B., Duran, F., Busatto Filho, G., Amaro Junior, E., et al. (2019). Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: evidence from the ELECT-TDCS trial. Brain stimulation, 12( 5), 1197-1204. doi:10.1016/j.brs.2019.05.006
NLM
Bulubas L, Padberg F, V PB, Duran F, Busatto Filho G, Amaro Junior E, Benseñor IJM, Lotufo PA, Goerigk S, Gattaz WF. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: evidence from the ELECT-TDCS trial [Internet]. Brain stimulation. 2019 ; 12( 5): 1197-1204.Available from: http://observatorio.fm.usp.br/handle/OPI/33551
Vancouver
Bulubas L, Padberg F, V PB, Duran F, Busatto Filho G, Amaro Junior E, Benseñor IJM, Lotufo PA, Goerigk S, Gattaz WF. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: evidence from the ELECT-TDCS trial [Internet]. Brain stimulation. 2019 ; 12( 5): 1197-1204.Available from: http://observatorio.fm.usp.br/handle/OPI/33551
Artigo de periodico
Schizophrenia treatment with electric Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial (2019)
Valiengo, Leandro; Gordon, Pedro Caldana; De Carvalho, Juliana Barbosa; Rios, Rosa Maria; Koebe, Stephanie; Serpa, Mauricio Henrique; Van De Bilt, Martinus; Lacerda, Acioly; Elkis, Helio ; Gattaz, Wagner Farid ; Brunoni, André Russowsky
Source: Trends in psychiatry and psychotherapy. Unidade: FM
Subjects: ESQUIZOFRENIA, ESTIMULAÇÃO CEREBRAL, TESTES PSICOLÓGICOS, BIOMARCADORES, ALUCINAÇÕES AUDITIVAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALIENGO, Leandro; GORDON, Pedro Caldana; DE CARVALHO, Juliana Barbosa; et al. Schizophrenia treatment with electric Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. Trends in psychiatry and psychotherapy, Porto Alegre, v. 41, n. 2, p. 104-111, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/33363 > DOI: 10.1590/2237-6089-2018-0047.
APA
Valiengo, L., Gordon, P. C., De Carvalho, J. B., Rios, R. M., Koebe, S., Serpa, M. H., et al. (2019). Schizophrenia treatment with electric Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. Trends in psychiatry and psychotherapy, 41( 2), 104-111. doi:10.1590/2237-6089-2018-0047
NLM
Valiengo L, Gordon PC, De Carvalho JB, Rios RM, Koebe S, Serpa MH, Van De Bilt M, Lacerda A, Elkis H, Gattaz WF, Brunoni AR. Schizophrenia treatment with electric Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial [Internet]. Trends in psychiatry and psychotherapy. 2019 ; 41( 2): 104-111.Available from: http://observatorio.fm.usp.br/handle/OPI/33363
Vancouver
Valiengo L, Gordon PC, De Carvalho JB, Rios RM, Koebe S, Serpa MH, Van De Bilt M, Lacerda A, Elkis H, Gattaz WF, Brunoni AR. Schizophrenia treatment with electric Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial [Internet]. Trends in psychiatry and psychotherapy. 2019 ; 41( 2): 104-111.Available from: http://observatorio.fm.usp.br/handle/OPI/33363
Artigo de periodico
Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: results of a 6-month follow-up (2019)
Aparício, Luana V M; Rosa, Vivianne; Razza, Lais M; Sampaio-Junior, Bernardo; Borrione, Lucas; Valiengo, Leandro; Lotufo, Paulo Andrade; Benseñor, Isabela M; Fraguas Junior, Renerio; Moffa, Adriano H; Gattaz, Wagner F; Brunoni, André Russowsky
Source: Depression and Anxiety. Unidades: FM, HU
Subjects: TRANSTORNO BIPOLAR, DEPRESSÃO, TERAPIA POR ESTIMULAÇÃO ELÉTRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APARÍCIO, Luana V M; ROSA, Vivianne; RAZZA, Lais M; et al. Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: results of a 6-month follow-up. Depression and Anxiety, New York, v. 36, n. 3, p. 262-268, 2019. Disponível em: < https://onlinelibrary.wiley.com/doi/epdf/10.1002/da.22878 > DOI: 10.1002/da.22878.
APA
Aparício, L. V. M., Rosa, V., Razza, L. M., Sampaio-Junior, B., Borrione, L., Valiengo, L., et al. (2019). Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: results of a 6-month follow-up. Depression and Anxiety, 36( 3), 262-268. doi:10.1002/da.22878
NLM
Aparício LVM, Rosa V, Razza LM, Sampaio-Junior B, Borrione L, Valiengo L, Lotufo PA, Benseñor IM, Fraguas Junior R, Moffa AH, Gattaz WF, Brunoni AR. Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: results of a 6-month follow-up [Internet]. Depression and Anxiety. 2019 ; 36( 3): 262-268.Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/da.22878
Vancouver
Aparício LVM, Rosa V, Razza LM, Sampaio-Junior B, Borrione L, Valiengo L, Lotufo PA, Benseñor IM, Fraguas Junior R, Moffa AH, Gattaz WF, Brunoni AR. Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: results of a 6-month follow-up [Internet]. Depression and Anxiety. 2019 ; 36( 3): 262-268.Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/da.22878
Artigo de periodico-carta/editorial
Plasma metabolites in first episode psychoses [Carta] (2019)
Costa, Alana C; Joaquim, Helena P. G; Talib, Leda L; Serpa, Mauricio H; Zanetti, Marcus V; Gattaz, Wagner Farid
Source: Schizophrenia research. Unidade: FM
Subjects: BIOMARCADORES, ESQUIZOFRENIA, MANIFESTAÇÕES NEUROLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C; JOAQUIM, Helena P. G; TALIB, Leda L; et al. Plasma metabolites in first episode psychoses [Carta]. Schizophrenia research[S.l: s.n.], 2019.Disponível em: DOI: 10.1016/j.schres.2018.11.010.
APA
Costa, A. C., Joaquim, H. P. G., Talib, L. L., Serpa, M. H., Zanetti, M. V., & Gattaz, W. F. (2019). Plasma metabolites in first episode psychoses [Carta]. Schizophrenia research. Amsterdam. doi:10.1016/j.schres.2018.11.010
NLM
Costa AC, Joaquim HPG, Talib LL, Serpa MH, Zanetti MV, Gattaz WF. Plasma metabolites in first episode psychoses [Carta] [Internet]. Schizophrenia research. 2019 ; 206 468-470.Available from: http://observatorio.fm.usp.br/handle/OPI/32524
Vancouver
Costa AC, Joaquim HPG, Talib LL, Serpa MH, Zanetti MV, Gattaz WF. Plasma metabolites in first episode psychoses [Carta] [Internet]. Schizophrenia research. 2019 ; 206 468-470.Available from: http://observatorio.fm.usp.br/handle/OPI/32524
Artigo de periodico
Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients (2019)
Joaquim, Helena P. G; Costa, Alana C; Forlenza, Orestes Vicente ; Gattaz, Wagner Farid ; Talib, Leda L
Source: Archives of clinical psychiatry. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, COMPROMETIMENTO COGNITIVO LEVE, AMINAS (COMPOSTOS ORGÂNICOS), PLASMA, BIOMARCADORES, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G; COSTA, Alana C; FORLENZA, Orestes Vicente; GATTAZ, Wagner Farid; TALIB, Leda L. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, Sao Paulo, v. 46, n. 5, p. 120-124, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/34527 > DOI: 10.1590/0101-60830000000209.
APA
Joaquim, H. P. G., Costa, A. C., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2019). Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, 46( 5), 120-124. doi:10.1590/0101-60830000000209
NLM
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.Available from: http://observatorio.fm.usp.br/handle/OPI/34527
Vancouver
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.Available from: http://observatorio.fm.usp.br/handle/OPI/34527
Artigo de periodico
Hearing spirits?: religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort (2019)
Loch, Alexandre Andrade; Freitas, Elder Lanzani; Hortencio, Lucas; Chianca, Camille; Alves, Tania Maria; Serpa, Mauricio Henriques; Andrade, Julio Cesar; Bilt, Martinus Theodorus van de; Gattaz, Wagner Farid; Roessler, Wulf
Source: Schizophrenia research. Unidade: FM
Subjects: TRANSTORNOS PSICOFISIOLÓGICOS, ESPIRITUALIDADE, ESTUDOS DE COORTES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOCH, Alexandre Andrade; FREITAS, Elder Lanzani; HORTENCIO, Lucas; et al. Hearing spirits?: religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort. Schizophrenia research, Amsterdam, v. 204, p. 353-359, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/31199 > DOI: 10.1016/j.schres.2018.09.020.
APA
Loch, A. A., Freitas, E. L., Hortencio, L., Chianca, C., Alves, T. M., Serpa, M. H., et al. (2019). Hearing spirits?: religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort. Schizophrenia research, 204, 353-359. doi:10.1016/j.schres.2018.09.020
NLM
Loch AA, Freitas EL, Hortencio L, Chianca C, Alves TM, Serpa MH, Andrade JC, Bilt MT van de, Gattaz WF, Roessler W. Hearing spirits?: religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort [Internet]. Schizophrenia research. 2019 ; 204 353-359.Available from: http://observatorio.fm.usp.br/handle/OPI/31199
Vancouver
Loch AA, Freitas EL, Hortencio L, Chianca C, Alves TM, Serpa MH, Andrade JC, Bilt MT van de, Gattaz WF, Roessler W. Hearing spirits?: religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort [Internet]. Schizophrenia research. 2019 ; 204 353-359.Available from: http://observatorio.fm.usp.br/handle/OPI/31199
Artigo de periodico
Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression (2018)
Brunoni, Andre R; Padberg, Frank; Vieira, Erica Leandro Marciano; Teixeira, Antonio Lucio; Carvalho, Andre F.; Lotufo, Paulo Andrade; Gattaz, Wagner F.; Benseñor, Isabela Judith Martins
Source: Progress in neuro-psychopharmacology & biological psychiatry. Unidade: FM
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS, INTERLEUCINAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNONI, Andre R; PADBERG, Frank; VIEIRA, Erica Leandro Marciano; et al. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Progress in neuro-psychopharmacology & biological psychiatry, Oxford, v. 86, p. 211-217, 2018. Disponível em: < http://dx.doi.org/10.1016/j.pnpbp.2018.06.003 > DOI: 10.1016/j.pnpbp.2018.06.003.
APA
Brunoni, A. R., Padberg, F., Vieira, E. L. M., Teixeira, A. L., Carvalho, A. F., Lotufo, P. A., et al. (2018). Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Progress in neuro-psychopharmacology & biological psychiatry, 86, 211-217. doi:10.1016/j.pnpbp.2018.06.003
NLM
Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IJM. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2018 ; 86 211-217.Available from: http://dx.doi.org/10.1016/j.pnpbp.2018.06.003
Vancouver
Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IJM. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2018 ; 86 211-217.Available from: http://dx.doi.org/10.1016/j.pnpbp.2018.06.003
Artigo de periodico
Genetic polymorphisms of the 5HT receptors are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis (2018)
Vincentiis, Silvia; Gattaz, Wagner F.; Busatto, Geraldo
Source: Epilepsy & behavior. Unidade: FM
Subjects: POLIMORFISMO, RECEPTORES DE NEUROTRANSMISSORES, EPILEPSIA, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINCENTIIS, Silvia; GATTAZ, Wagner F.; BUSATTO, Geraldo. Genetic polymorphisms of the 5HT receptors are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis. Epilepsy & behavior, San Diego, v. 83, p. 181-185, 2018. Disponível em: < http://dx.doi.org/10.1016/j.yebeh.2018.03.032 > DOI: 10.1016/j.yebeh.2018.03.032.
APA
Vincentiis, S., Gattaz, W. F., & Busatto, G. (2018). Genetic polymorphisms of the 5HT receptors are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis. Epilepsy & behavior, 83, 181-185. doi:10.1016/j.yebeh.2018.03.032
NLM
Vincentiis S, Gattaz WF, Busatto G. Genetic polymorphisms of the 5HT receptors are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis [Internet]. Epilepsy & behavior. 2018 ; 83 181-185.Available from: http://dx.doi.org/10.1016/j.yebeh.2018.03.032
Vancouver
Vincentiis S, Gattaz WF, Busatto G. Genetic polymorphisms of the 5HT receptors are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis [Internet]. Epilepsy & behavior. 2018 ; 83 181-185.Available from: http://dx.doi.org/10.1016/j.yebeh.2018.03.032
Artigo de periodico
Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients (2018)
Joaquim, Helena P. G.; Costa, Alana C.; Gattaz, Wagner F.; Talib, Leda Leme
Source: Journal of neural transmission. Unidade: FM
Subjects: ESCALAS DE GRADUAÇÃO PSIQUIÁTRICA, PSICODIAGNÓSTICO, ESQUIZOFRENIA, INFLAMAÇÃO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G.; COSTA, Alana C.; GATTAZ, Wagner F.; TALIB, Leda Leme. Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients. Journal of neural transmission, Wien, v. 125, n. 5, p. 869-873, 2018. Disponível em: < http://dx.doi.org/10.1007/s00702-018-1838-8 > DOI: 10.1007/s00702-018-1838-8.
APA
Joaquim, H. P. G., Costa, A. C., Gattaz, W. F., & Talib, L. L. (2018). Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients. Journal of neural transmission, 125( 5), 869-873. doi:10.1007/s00702-018-1838-8
NLM
Joaquim HPG, Costa AC, Gattaz WF, Talib LL. Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients [Internet]. Journal of neural transmission. 2018 ; 125( 5): 869-873.Available from: http://dx.doi.org/10.1007/s00702-018-1838-8
Vancouver
Joaquim HPG, Costa AC, Gattaz WF, Talib LL. Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients [Internet]. Journal of neural transmission. 2018 ; 125( 5): 869-873.Available from: http://dx.doi.org/10.1007/s00702-018-1838-8
Artigo de periodico
Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder (2018)
Munkholm, Klaus; Gattaz, Wagner Farid
Source: European neuropsychopharmacology. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, APTIDÃO COGNITIVA, LÍTIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNKHOLM, Klaus; GATTAZ, Wagner Farid. Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder. European neuropsychopharmacology, Amsterdam, v. 28, n. 3, p. 361-368, 2018. Disponível em: < http://dx.doi.org/10.1016/j.euroneuro.2018.01.008 > DOI: 10.1016/j.euroneuro.2018.01.008.
APA
Munkholm, K., & Gattaz, W. F. (2018). Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder. European neuropsychopharmacology, 28( 3), 361-368. doi:10.1016/j.euroneuro.2018.01.008
NLM
Munkholm K, Gattaz WF. Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder [Internet]. European neuropsychopharmacology. 2018 ; 28( 3): 361-368.Available from: http://dx.doi.org/10.1016/j.euroneuro.2018.01.008
Vancouver
Munkholm K, Gattaz WF. Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder [Internet]. European neuropsychopharmacology. 2018 ; 28( 3): 361-368.Available from: http://dx.doi.org/10.1016/j.euroneuro.2018.01.008
Artigo de periodico
Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice (2018)
Cardillo, Giancarlo de Mattos; Catanozi, Sergio; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Journal of alzheimers disease. Unidade: FM
Subjects: TELÔMERO, DOENÇA DE ALZHEIMER, LÍTIO, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDILLO, Giancarlo de Mattos; CATANOZI, Sergio; GATTAZ, Wagner Farid; FORLENZA, Orestes Vicente. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. Journal of alzheimers disease, Amsterdam, v. 63, n. 1, p. 93-101, 2018. Disponível em: < http://dx.doi.org/10.3233/JAD-170838 > DOI: 10.3233/JAD-170838.
APA
Cardillo, G. de M., Catanozi, S., Gattaz, W. F., & Forlenza, O. V. (2018). Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. Journal of alzheimers disease, 63( 1), 93-101. doi:10.3233/JAD-170838
NLM
Cardillo G de M, Catanozi S, Gattaz WF, Forlenza OV. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice [Internet]. Journal of alzheimers disease. 2018 ; 63( 1): 93-101.Available from: http://dx.doi.org/10.3233/JAD-170838
Vancouver
Cardillo G de M, Catanozi S, Gattaz WF, Forlenza OV. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice [Internet]. Journal of alzheimers disease. 2018 ; 63( 1): 93-101.Available from: http://dx.doi.org/10.3233/JAD-170838
Artigo de periodico
Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial (2018)
Myczkowski, Martin L.; Lafer, Beny; Gattaz, Wagner
Source: Journal of affective disorders. Unidade: FM
Subjects: ESTUDOS RANDOMIZADOS, ESTIMULAÇÃO ELÉTRICA, DEPRESSÃO, COGNIÇÃO, TRANSTORNOS COGNITIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MYCZKOWSKI, Martin L.; LAFER, Beny; GATTAZ, Wagner. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial. Journal of affective disorders, Amsterdam, v. 235, p. 20-26, 2018. Disponível em: < http://dx.doi.org/10.1016/j.jad.2018.04.022 > DOI: 10.1016/j.jad.2018.04.022.
APA
Myczkowski, M. L., Lafer, B., & Gattaz, W. (2018). Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial. Journal of affective disorders, 235, 20-26. doi:10.1016/j.jad.2018.04.022
NLM
Myczkowski ML, Lafer B, Gattaz W. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial [Internet]. Journal of affective disorders. 2018 ; 235 20-26.Available from: http://dx.doi.org/10.1016/j.jad.2018.04.022
Vancouver
Myczkowski ML, Lafer B, Gattaz W. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial [Internet]. Journal of affective disorders. 2018 ; 235 20-26.Available from: http://dx.doi.org/10.1016/j.jad.2018.04.022

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Normalized affiliation

Non normalized affiliation

Keywords